Evidence map›Paper›PMID 24587194›Full record

ArticlePloS one2014

Regulation of hERG and hEAG channels by Src and by SHP-1 tyrosine phosphatase via an ITIM region in the cyclic nucleotide binding domain.

Lyanne C Schlichter, Jiahua Jiang, John Wang, Evan W Newell, Florence W L Tsui, Doris Lam

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lyanne C SchlichterGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada ; Department of Physiology University of Toronto, Toronto, Ontario, Canada.
Jiahua JiangGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.
John WangGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.
Evan W NewellGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada ; Department of Physiology University of Toronto, Toronto, Ontario, Canada.
Florence W L TsuiGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada ; Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Doris LamGenes and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada ; Department of Physiology University of Toronto, Toronto, Ontario, Canada.
University of Toronto · CAUniversity Health Network · CA

Funding

The Role of Membrane Potential in Microglia ActivationF31NS049742 · NINDS · UNIVERSITY HEALTH NETWORK · PI NEWELL, EVAN W · 2004 to 2005
$52k
CIHR 64402NINDS NIH HHS F31 NS049742NINDS NIH HHS F31NS049742
6 · The paper itself

Abstract

Members of the EAG K(+) channel superfamily (EAG/Kv10.x, ERG/Kv11.x, ELK/Kv12.x subfamilies) are expressed in many cells and tissues. In particular, two prototypes, EAG1/Kv10.1/KCNH1 and ERG1/Kv11.1/KCNH2 contribute to both normal and pathological functions. Proliferation of numerous cancer cells depends on hEAG1, and in some cases, hERG. hERG is best known for contributing to the cardiac action potential, and for numerous channel mutations that underlie 'long-QT syndrome'. Many cells, particularly cancer cells, express Src-family tyrosine kinases and SHP tyrosine phosphatases; and an imbalance in tyrosine phosphorylation can lead to malignancies, autoimmune diseases, and inflammatory disorders. Ion channel contributions to cell functions are governed, to a large degree, by post-translational modulation, especially phosphorylation. However, almost nothing is known about roles of specific tyrosine kinases and phosphatases in regulating K(+) channels in the EAG superfamily. First, we show that tyrosine kinase inhibitor, PP1, and the selective Src inhibitory peptide, Src40-58, reduce the hERG current amplitude, without altering its voltage dependence or kinetics. PP1 similarly reduces the hEAG1 current. Surprisingly, an 'immuno-receptor tyrosine inhibitory motif' (ITIM) is present within the cyclic nucleotide binding domain of all EAG-superfamily members, and is conserved in the human, rat and mouse sequences. When tyrosine phosphorylated, this ITIM directly bound to and activated SHP-1 tyrosine phosphatase (PTP-1C/PTPN6/HCP); the first report that a portion of an ion channel is a binding site and activator of a tyrosine phosphatase. Both hERG and hEAG1 currents were decreased by applying active recombinant SHP-1, and increased by the inhibitory substrate-trapping SHP-1 mutant. Thus, hERG and hEAG1 currents are regulated by activated SHP-1, in a manner opposite to their regulation by Src. Given the widespread distribution of these channels, Src and SHP-1, this work has broad implications in cell signaling that controls survival, proliferation, differentiation, and other ERG1 and EAG1 functions in many cell types.

Indexed as

Gene Expression RegulationAction PotentialsAmino Acid SequenceAnimalsConserved SequenceCyclic AMPERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsHEK293 CellsHumansMiceMolecular Sequence DataPatch-Clamp TechniquesPeptidesProtein BindingProtein Structure, Tertiary4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidineCyclic AMPERG1 Potassium ChannelEther-A-Go-Go Potassium ChannelsKCNH1 protein, humanKCNH2 protein, humanKcnh2 protein, mouseKcnh2 protein, ratPeptidesProtein Tyrosine Phosphatase, Non-Receptor Type 6PyrazolesPyrimidinesSrc40-58 peptidesrc-Family Kinases

Identifiers

PMID24587194
PMCPMC3938566
OpenAlexW2081575623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.